Regeneron Pharmaceuticals Inc (REGN)

Francoforte
Valuta in EUR
700,000
-1,000(-0,14%)
Chiuso

Conto Economico REGN

Conto economico avanzato
Fine Periodo:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Totale fatturato
aa.aaaa.aaaa.aaaa.aaaa.aa8.497,116.071,712.172,913.117,214.202
Totale crescita fatturato
aa.aaaa.aaaa.aaaa.aaaa.aa+29,58%+89,14%-24,26%+7,76%+8,27%
Costo del venduto
aa.aaaa.aaaa.aaaa.aaaa.aa3.766,95.297,65.152,96.254,87.102,5
Utile Lordo
aa.aaaa.aaaa.aaaa.aaaa.aa4.730,210.774,17.0206.862,47.099,5
Crescita utile lordo
aa.aaaa.aaaa.aaaa.aaaa.aa+41,52%+127,77%-34,84%-2,25%+3,46%
Margine profitti lordi
aa.aaaa.aaaa.aaaa.aaaa.aa55,67%67,04%57,67%52,32%49,99%
Altre spese operative, totale
aa.aaaa.aaaa.aaaa.aaaa.aa1.065,61.779,32.0262.629,22.954,4
Altre spese operative, crescita totale
Spese per Ricerca e Sviluppo
Vendite, Spese generali ed amministrative
Altre spese operative
aa.aaaa.aaaa.aaaa.aaaa.aa-5,92%+66,98%+13,87%+29,77%+12,37%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa1.3461.824,92.115,92.631,32.954,4
aa.aaaa.aaaa.aaaa.aaaa.aa-280,4-45,6-89,9-2,1-
Reddito operativo
aa.aaaa.aaaa.aaaa.aaaa.aa3.664,68.994,84.9944.233,24.145,1
Crescita reddito operativo
aa.aaaa.aaaa.aaaa.aaaa.aa+65,83%+145,45%-44,48%-15,23%-2,08%
Margine % EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa43,13%55,97%41,03%32,27%29,19%
Spesa netta per interessi
aa.aaaa.aaaa.aaaa.aaaa.aa18,5-11,5100,7422,9656,2
Crescita spesa netta per interessi
aa.aaaa.aaaa.aaaa.aaaa.aa+161,26%-162,16%+975,65%+319,96%+55,17%
Spesa per interessi, totale
aa.aaaa.aaaa.aaaa.aaaa.aa-56,9-57,3-59,4-73-55,2
Reddito da interessi e investimenti
aa.aaaa.aaaa.aaaa.aaaa.aa75,445,8160,1495,9711,4
Altre spese non operative, totale
aa.aaaa.aaaa.aaaa.aaaa.aa19,34,459-32,915,3
EBT escluse voci inusuali
aa.aaaa.aaaa.aaaa.aaaa.aa3.702,48.987,75.153,74.623,24.816,6
Guadagno (Perdita) sulla vendita degli asset
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Altre voci inusuali, totale
aa.aaaa.aaaa.aaaa.aaaa.aa-88-48-255,1-186,1-154,4
EBT, comprese voci insolite
aa.aaaa.aaaa.aaaa.aaaa.aa3.810,49.325,84.858,84.199,34.779,9
Crescita EBT, comprese voci inusuali
aa.aaaa.aaaa.aaaa.aaaa.aa+56,86%+144,75%-47,9%-13,57%+13,83%
EBT, compreso margine voci inusuali
aa.aaaa.aaaa.aaaa.aaaa.aa44,84%58,03%39,91%32,01%33,66%
Tasse sui redditi
aa.aaaa.aaaa.aaaa.aaaa.aa297,21.250,5520,4245,7367,3
Reddito netto società
aa.aaaa.aaaa.aaaa.aaaa.aa3.513,28.075,34.338,43.953,64.412,6
Interessi di minoranza
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Reddito netto
aa.aaaa.aaaa.aaaa.aaaa.aa3.513,28.075,34.338,43.953,64.412,6
Crescita reddito netto
aa.aaaa.aaaa.aaaa.aaaa.aa+66,05%+129,86%-46,28%-8,87%+11,61%
Margine % reddito netto
aa.aaaa.aaaa.aaaa.aaaa.aa41,35%50,25%35,64%30,14%31,07%
Dividendo privilegiati e altri adeguamenti
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Utile netto comune escluse voci extra
aa.aaaa.aaaa.aaaa.aaaa.aa3.513,28.075,34.338,43.953,64.412,6
EPS base - reddito operativo
aa.aaaa.aaaa.aaaa.aaaa.aa32,6576,440,5137,0540,9
EPS base - crescita reddito operativo
aa.aaaa.aaaa.aaaa.aaaa.aa+68,52%+133,99%-46,98%-8,53%+10,37%
EPS diluiti - reddito operativo
aa.aaaa.aaaa.aaaa.aaaa.aa30,5271,9738,2234,7738,34
EPS diluiti - crescita reddito operativo
aa.aaaa.aaaa.aaaa.aaaa.aa+65,33%+135,81%-46,89%-9,03%+10,27%
Base azioni medie ponderate in circolazione
aa.aaaa.aaaa.aaaa.aaaa.aa107,6105,7107,1106,7107,9
Azioni medie ponderate diluite in circolazione
aa.aaaa.aaaa.aaaa.aaaa.aa115,1112,2113,5113,7115,1
Dividendo per azione
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Crescita dividendo per azione
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa3.900,59.2815.335,44.654,24.628
Crescita EBITDA
aa.aa